Literature DB >> 18664480

Lifetime and age-conditional probabilities of developing or dying of cancer in Japan.

Ken-ichi Kamo1, Kota Katanoda, Tomohiro Matsuda, Tomomi Marugame, Wakiko Ajiki, Tomotaka Sobue.   

Abstract

The concepts of lifetime and age-conditional probabilities of developing and dying of cancer are introduced as indexes to understand the risk of cancer. In this paper, we estimated the lifetime and age-conditional probabilities of developing and dying of cancer in 2001 and 2005, respectively, in Japan. It is estimated that one in two Japanese males and one in three females will develop cancer, and one in four Japanese males and one in six females will die of cancer. Moreover, the probabilities of developing cancer within specific decades of age are obtained as the short-term risks.

Entities:  

Mesh:

Year:  2008        PMID: 18664480     DOI: 10.1093/jjco/hyn061

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  10 in total

1.  Incidence of metachronous second primary cancers in Osaka, Japan: update of analyses using population-based cancer registry data.

Authors:  Takahiro Tabuchi; Yuri Ito; Akiko Ioka; Isao Miyashiro; Hideaki Tsukuma
Journal:  Cancer Sci       Date:  2012-04-11       Impact factor: 6.716

2.  Evaluation of Oncotype DX Recurrence Score as a prognostic factor in Japanese women with estrogen receptor-positive, node-negative primary Stage I or IIA breast cancer.

Authors:  Kyoko Yorozuya; Toru Takeuchi; Miwa Yoshida; Yukako Mouri; Junko Kousaka; Kimihito Fujii; Shogo Nakano; Takashi Fukutomi; Kazuo Hara; Shu Ichihara; Yingsong Lin; Shogo Kikuchi
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-28       Impact factor: 4.553

3.  Quantification of the increase in thyroid cancer prevalence in Fukushima after the nuclear disaster in 2011--a potential overdiagnosis?

Authors:  Kota Katanoda; Ken-Ichi Kamo; Shoichiro Tsugane
Journal:  Jpn J Clin Oncol       Date:  2016-01-10       Impact factor: 3.019

4.  Analysis of the Clinicopathological Characteristics and Risk Factors in Patients with Lung Cancer and Chronic Obstructive Pulmonary Disease.

Authors:  Jian-Long Miao; Jing-Jing Cai; Xiao-Feng Qin; Rui-Juan Liu
Journal:  Biomed Res Int       Date:  2018-02-14       Impact factor: 3.411

Review 5.  Recognising Lung Cancer in Primary Care.

Authors:  Stephen H Bradley; Martyn P T Kennedy; Richard D Neal
Journal:  Adv Ther       Date:  2018-11-29       Impact factor: 3.845

6.  Incidence, Mortality Features and Lifetime Risk Estimation of Digestive Tract Cancers in an Urban District of Shanghai, China.

Authors:  Jing-Hao Bi; Hui-Yun Yuan; Yu Jiang; Yun Zhang; Wen-Wei Zheng; Lei Zhang; Zhuo-Ying Li; Hong-Lan Li; Yu-Ting Tan; Wen-Sui Zhao; Yong-Bing Xiang
Journal:  J Epidemiol Glob Health       Date:  2022-06-25

7.  Societal cost-effectiveness analysis of the 21-gene assay in estrogen-receptor-positive, lymph-node-negative early-stage breast cancer in Japan.

Authors:  Hideko Yamauchi; Chizuko Nakagawa; Shinji Yamashige; Hiroyuki Takei; Hiroshi Yagata; Atsushi Yoshida; Naoki Hayashi; John Hornberger; Tiffany Yu; Calvin Chao; Carl Yoshizawa; Seigo Nakamura
Journal:  BMC Health Serv Res       Date:  2014-09-05       Impact factor: 2.655

Review 8.  The relationship between COPD and lung cancer.

Authors:  A L Durham; I M Adcock
Journal:  Lung Cancer       Date:  2015-08-29       Impact factor: 5.705

9.  Lifetime and age-conditional risk estimates of end-stage kidney disease requiring maintenance dialysis in Japan.

Authors:  Minako Wakasugi; Ichiei Narita
Journal:  Clin Exp Nephrol       Date:  2020-02-10       Impact factor: 2.801

10.  Estimation of lifetime cumulative incidence and mortality risk of gastric cancer.

Authors:  Yukari Taniyama; Kota Katanoda; Hadrien Charvat; Megumi Hori; Yuko Ohno; Shizuka Sasazuki; Shoichiro Tsugane
Journal:  Jpn J Clin Oncol       Date:  2017-11-01       Impact factor: 3.019

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.